Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

External Validation of a Multiplex Urinary Protein Panel for the Detection of Bladder Cancer in a Multicenter Cohort.

Chen LM, Chang M, Dai Y, Chai KX, Dyrskj√łt L, Sanchez-Cabayo M, Szarvas T, Zwarthoff EC, Lokeswhar V, Jeronimo C, Parker AS, Ross S, Borre M, Orntoft TF, Jaeger T, Beukers W, Lopez LE, Henrique R, Young PR, Urquidi V, Goodison S, Rosser CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Jun 11. pii: cebp.0029.2014. [Epub ahead of print]

PMID:
24920641
[PubMed - as supplied by publisher]
2.

Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.

Gomes-Giacoia E, Miyake M, Goodison S, Sriharan A, Zhang G, You L, Egan JO, Rhode PR, Parker AS, Chai KX, Wong HC, Rosser CJ.

PLoS One. 2014 Jun 4;9(6):e96705. doi: 10.1371/journal.pone.0096705. eCollection 2014.

PMID:
24896845
[PubMed - in process]
Free PMC Article
3.

Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.

Zhang G, Miyake M, Lawton A, Goodison S, Rosser CJ.

BMC Cancer. 2014 May 3;14:310. doi: 10.1186/1471-2407-14-310.

PMID:
24885595
[PubMed - in process]
Free PMC Article
4.

Urinary protein biomarker panel for the detection of recurrent bladder cancer.

Rosser CJ, Chang M, Dai Y, Ross S, Mengual L, Alcaraz A, Goodison S.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1340-5. doi: 10.1158/1055-9965.EPI-14-0035. Epub 2014 Apr 8.

PMID:
24714076
[PubMed - in process]
5.

Simultaneous multi-analyte urinary protein assay for bladder cancer detection.

Rosser CJ, Dai Y, Miyake M, Zhang G, Goodison S.

BMC Biotechnol. 2014 Apr 1;14:24. doi: 10.1186/1472-6750-14-24.

PMID:
24684904
[PubMed - in process]
Free Article
6.

Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.

Miyake M, Goodison S, Lawton A, Gomes-Giacoia E, Rosser CJ.

Oncogene. 2014 Feb 24. doi: 10.1038/onc.2014.2. [Epub ahead of print]

PMID:
24561529
[PubMed - as supplied by publisher]
7.

MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS.

Urquidi V, Rosser CJ, Goodison S.

Eur Med J Urol. 2013;1:70-73.

PMID:
24533178
[PubMed]
Free PMC Article
8.

Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer.

Miyake M, Lawton A, Dai Y, Chang M, Mengual L, Alcaraz A, Goodison S, Rosser CJ.

BMC Cancer. 2014 Feb 13;14:86. doi: 10.1186/1471-2407-14-86.

PMID:
24524203
[PubMed - in process]
Free PMC Article
9.

Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Popescu NC, Goodison S.

Mol Diagn Ther. 2014 Jun;18(3):293-302. doi: 10.1007/s40291-014-0086-3.

PMID:
24519699
[PubMed - in process]
10.

PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.

Giacoia EG, Miyake M, Lawton A, Goodison S, Rosser CJ.

Mol Cancer Res. 2014 Mar;12(3):322-34. doi: 10.1158/1541-7786.MCR-13-0543. Epub 2014 Jan 24.

PMID:
24464915
[PubMed - in process]
11.

Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer.

Miyake M, Lawton A, Goodison S, Urquidi V, Rosser CJ.

Pathol Res Pract. 2014 Feb;210(2):74-8. doi: 10.1016/j.prp.2013.08.013. Epub 2013 Oct 28.

PMID:
24252309
[PubMed - in process]
12.

Targeting plasminogen activator inhibitor-1 inhibits angiogenesis and tumor growth in a human cancer xenograft model.

Gomes-Giacoia E, Miyake M, Goodison S, Rosser CJ.

Mol Cancer Ther. 2013 Dec;12(12):2697-708. doi: 10.1158/1535-7163.MCT-13-0500. Epub 2013 Sep 26.

PMID:
24072883
[PubMed - in process]
13.

Urinary biomarkers of bladder cancer: an update and future perspectives.

Rosser CJ, Urquidi V, Goodison S.

Biomark Med. 2013 Oct;7(5):779-90. doi: 10.2217/bmm.13.73. Review.

PMID:
24044570
[PubMed - indexed for MEDLINE]
14.

Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation.

Sankpal UT, Lee CM, Connelly SF, Kayaleh O, Eslin D, Sutphin R, Goodison S, Adwan L, Zawia NH, Lichtenberger LM, Basha R.

Cell Physiol Biochem. 2013;32(3):675-86. doi: 10.1159/000354471. Epub 2013 Sep 10.

PMID:
24030139
[PubMed - indexed for MEDLINE]
15.

Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection.

Miyake M, Ross S, Lawton A, Chang M, Dai Y, Mengual L, Alcaraz A, Giacoia EG, Goodison S, Rosser CJ.

BMC Urol. 2013 Sep 5;13:42. doi: 10.1186/1471-2490-13-42.

PMID:
24011266
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.

Miyake M, Goodison S, Lawton A, Zhang G, Gomes-Giacoia E, Rosser CJ.

J Hematol Oncol. 2013 Sep 3;6:65. doi: 10.1186/1756-8722-6-65.

PMID:
24004818
[PubMed - in process]
Free PMC Article
17.

Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.

Miyake M, Lawton A, Goodison S, Urquidi V, Gomes-Giacoia E, Zhang G, Ross S, Kim J, Rosser CJ.

BMC Cancer. 2013 Jul 1;13:322. doi: 10.1186/1471-2407-13-322.

PMID:
23815949
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Multiplex protein signature for the detection of bladder cancer in voided urine samples.

Rosser CJ, Ross S, Chang M, Dai Y, Mengual L, Zhang G, Kim J, Urquidi V, Alcaraz A, Goodison S.

J Urol. 2013 Dec;190(6):2257-62. doi: 10.1016/j.juro.2013.06.011. Epub 2013 Jun 11.

PMID:
23764080
[PubMed - indexed for MEDLINE]
19.

Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways.

Miyake M, Goodison S, Urquidi V, Gomes Giacoia E, Rosser CJ.

Lab Invest. 2013 Jul;93(7):768-78. doi: 10.1038/labinvest.2013.71. Epub 2013 Jun 3.

PMID:
23732813
[PubMed - indexed for MEDLINE]
Free Article
20.

Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests.

Goodison S, Rosser CJ, Urquidi V.

Mol Diagn Ther. 2013 Apr;17(2):71-84. doi: 10.1007/s40291-013-0023-x. Review.

PMID:
23479428
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk